Progressive multifocal leukoencephalopathy and natalizumab-Reference-Cited by-同舟云学术

Progressive multifocal leukoencephalopathy and natalizumab

Published:2011-06-07 Issue:11 Volume:258 Page:1920-1928
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Hellwig Kerstin,Gold Ralf

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-011-6116-8.pdf

Reference57 articles.

1. Polman CH, O’Connor PW, Havrdova E et al (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 354:889–910

2. Miller DH, Soon D, Fernando KT et al (2007) MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology 68:1390–1401

3. Munschauer F, Giovannoni G, Lublin F et al (2008) Natalizumab significantly increases the cumulative probability of sustained improvement in physical disability. Mult Scler 14(Suppl 1):S168

4. Hutchinson M, Kappos L, Calabresi PA, For the AFFIRM and SENTINEL Investigators et al (2009) The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol 256:405–415

5. Havrdova E, Galetta S, Hutchinson M et al (2009) Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol 8:254–260

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatological Neoplastic Diseases Complicating Treatment with Monoclonal Antibodies for Multiple Sclerosis;Journal of Clinical Medicine;2024-08-29

2. Intact natalizumab pharmacokinetics is impacted by endogenous IgG4 concentration;Multiple Sclerosis and Related Disorders;2024-07

3. Integrin α3 promotes T _H 17 cell polarization and extravasation during autoimmune neuroinflammation;Science Immunology;2023-10-27

4. Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years;Pharmaceuticals;2023-09-08

5. Peptide Mimotope-Enabled Quantification of Natalizumab Arm Exchange During Multiple Sclerosis Treatment;Therapeutic Drug Monitoring;2023-02